Method development and validation for simultaneous determination of six tyrosine kinase inhibitors and two active metabolites in human plasma/serum using UPLC–MS/MS for therapeutic drug monitoring
2018 ◽
Vol 56
(6)
◽
pp. 510-517
◽
2008 ◽
Vol 46
(3)
◽
pp. 491-497
◽
2018 ◽
Vol 8
(4)
◽
pp. 203